Clincosm LogoSign in Get a demo

Acute Myeloid Leukemia

Showing NaN - NaN of 178
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • DSP107
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

Completed
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
Nov 14, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in United States (PRT1419)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Orange City, Florida
  • +7 more
Oct 31, 2022

Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

Acute Myeloid Leukemia Trial in United Kingdom, United States (Arm 1: NTLA-5001, Arm 2: NTLA-5001)

Terminated
  • Acute Myeloid Leukemia
  • Arm 1: NTLA-5001
  • Arm 2: NTLA-5001
  • Los Angeles, California
  • +9 more
Oct 13, 2022

Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +1 more
Oct 7, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte, New York, Houston (BTX-A51)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +2 more
Sep 8, 2022

Acute Myeloid Leukemia, Stem Cell Transplantation Trial in United States (MT-401)

Recruiting
  • Acute Myeloid Leukemia
  • Stem Cell Transplantation
  • Birmingham, Alabama
  • +15 more
Aug 22, 2022

Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
  • +23 more
Aug 18, 2022

Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

Recruiting
  • Acute Myeloid Leukemia
  • Decitabine and Cedazuridine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Acute Myeloid Leukemia Trial in United States (Cyclophosphamide, Fludarabine, KITE-222)

Recruiting
  • Acute Myeloid Leukemia
  • Stanford, California
  • +6 more
Aug 10, 2022

Acute Myeloid Leukemia Trial in Worldwide (SEL24/MEN1703)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Atlanta, Georgia
  • +14 more
Aug 3, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +15 more
Jul 29, 2022

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

Recruiting
  • AML
  • +6 more
  • Gilbert, Arizona
  • +7 more
Jul 8, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Acute Myeloid Leukemia Trial in United States (ERAS-007, ERAS-601, Gilteritinib)

Withdrawn
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +3 more
Jun 13, 2022

Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • AML, Adult
  • Chicago, Illinois
  • +4 more
Jun 7, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (MultiTAA-specific T cells)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • MultiTAA-specific T cells
  • Houston, Texas
  • +1 more
May 31, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022